Ipca Laboratories Ltd. (IPCA)

Currency in INR
1,734.20
-62.10(-3.46%)
Closed·

Ipca Laboratories Earnings

Latest Release
13-08-2026
EPS / Forecast
15.84 / 12.43
Revenue / Forecast
27.88B / 25.89B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09-2026--/----/27.80B----Free Sign Up
06-202615.84/12.4327.88B/25.89B+27.43%+7.69%Free Sign Up
03-202611.80/9.3323.89B/23.68B+26.47%+0.89%Free Sign Up
12-202512.20/11.2223.93B/24.89B+8.73%-3.86%Free Sign Up
09-202513.10/11.1025.57B/25.27B+18.02%+1.19%Free Sign Up
06-20259.19/8.8523.09B/23.17B+3.84%-0.35%Free Sign Up
03-20258.74/--22.47B/22.19B--+1.26%Free Sign Up
12-20249.78/8.4522.45B/22.66B+15.74%-0.93%Free Sign Up
09-20249.05/9.0023.55B/23.20B+0.56%+1.51%Free Sign Up
06-20247.60/8.6120.93B/20.92B-11.73%+0.05%Free Sign Up

All numbers in INR

Ipca Laboratories Ltd. Earnings Call Summary for Q1/2027

  • Ipca Labs Q1 FY27 EPS of 15.84 beat estimates by 27.4%; revenue rose 21% YoY to 27.88B rupees, exceeding forecasts by 7.7%.
  • Consolidated EBITDA margin expanded 449 bps to 22.88% from 18.39%, driven by improved product mix and operating leverage.
  • Company raised FY27 revenue growth guidance to 14%-16% from 12%-13%; lifted EBITDA margin outlook to 23% from 22%.
  • Export sales surged 34% led by 70% growth in EU; U.S. business up 8% with 15%-17% growth expected for full year.
  • Management eliminated working capital debt, plans 700-800 crore capex in FY27; biosimilar revenue expected only in FY29-30.
Last Updated: 14-08-2026, 04:52 pm
Read Full Transcript

FAQ

What Is Ipca Laboratories's Earnings Per Share (TTM)?

The Ipca Laboratories EPS (TTM) is 44.98.

When Is The Next Ipca Laboratories Earnings Date?

Ipca Laboratories will release its next earnings report on 09-11-2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.